HelenGayleCicirelloMD

Medical Director, Chiesi Pharmaceuticals Inc.

Dr. Cicirello is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Office
9850 Key West Ave
Chiesi Pharmaceuticals, Inc.
Rockville, MD 20850
Phone+1 301-424-2661
Is this information wrong?

PubMed

CHF5074 reduces biomarkers of neuroinflammation in patients with mild cognitive impairment: a 12-week, double-blind, placebo-controlled study.
Ross J Sharma S Winston J Nunez M Bottini G Franceschi M Scarpini E Frigerio E Fiorentini F Fernandez M Sivilia S Giardino L Calza L Norris D Cicirello H Casula D Imbi...> ;Curr Alzheimer Res. 2013 Sep
12 citations
Pharmacokinetic and tolerability profiles of tobramycin nebuliser solution 300 mg/4 ml administered by PARI eFlow(®) rapid and PARI LC Plus(®) nebulisers in cystic fib...
Mirco Govoni, Gianluigi Poli, Daniela Acerbi, Debora Santoro, Helen Cicirello, Ottavia Annoni, Jozef Ružička> ;Pulmonary Pharmacology & Therapeutics. 2013 Apr 1
40 citations
Disease burden and risk factors for hospitalizations associated with rotavirus infection among children in New York State, 1989 through 2000.
Hwa Gan H. Chang, Roger I. Glass, Perry F. Smith, Helen G. Cicirello, Robert C. Holman, Dale L. Morse> ;The Pediatric Infectious Disease Journal. 2003 Sep 1